Jean-Paul Clozel
Chief Executive Officer bei IDORSIA LTD
Ursprung des Netzwerks ersten Grades von Jean-Paul Clozel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
37
| Subsidiary | Pharmaceuticals: Major | 37 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
30
| Subsidiary | Pharmaceuticals: Major | 30 |
21
| Public Company | Pharmaceuticals: Major | 21 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jean-Paul Clozel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CELGENE | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Chairman General Counsel Corporate Officer/Principal Corporate Secretary Corporate Officer/Principal Chairman | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO President President Corporate Officer/Principal Director of Finance/CFO | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| CITIGROUP INC. | Major Banks | Director/Board Member Corporate Officer/Principal | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
| ABB LTD | Electrical Products | Director/Board Member Director of Finance/CFO | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing General Counsel Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer Chief Executive Officer | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Founder Director/Board Member | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Founder Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree Doctorate Degree | |
| University of Basel | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| University of Bern | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Chairman Chairman | |
| ESSEC Business School | College/University | Masters Business Admin Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Chairman General Counsel | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Chairman | |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Roche Diagnostics France SASU
 Roche Diagnostics France SASU Medical SpecialtiesHealth Technology Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Undergraduate Degree Undergraduate Degree | |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Pharmaceuticals: Major | Human Resources Officer Director of Finance/CFO | |
Max Planck Florida Institute for Neuroscience
 Max Planck Florida Institute for Neuroscience Miscellaneous Commercial ServicesCommercial Services Max Planck Florida Institute for Neuroscience provides research services. It offers its services for neurobiology, brain function, neural circuits, neurological disorders, synaptic networks and bio-imaging. The company was founded in 2008 and is headquartered in Jupiter, FL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Actelion Pharmaceuticals Korea Ltd.
 Actelion Pharmaceuticals Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Korea Ltd. is a South Korean pharmaceutical company that manufactures pharmaceutical products. The private company is based in Seoul, South Korea. The company was founded in 1983. The CEO is Jenny Jeong. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Biotechnology | Chairman Director/Board Member | |
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a private company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Max Planck Institute For Biophysical Chemistry | College/University | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 16 |
| Schweiz | 16 |
| Frankreich | 9 |
| Deutschland | 5 |
| Japan | 4 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 14 |
| Finance | 4 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 462 |
| Corporate Officer/Principal | 181 |
| Chairman | 145 |
| Independent Dir/Board Member | 99 |
| Chief Executive Officer | 59 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Heiner Dreismann | 46 |
| Franz Humer | 45 |
| Jean-Luc Bélingard | 40 |
| Erich Maximilian Platzer | 31 |
| Jean-Pierre Garnier | 28 |
| Michel de Rosen | 28 |
| Felix R. Ehrat | 27 |
| Leonard Patrick Gage | 26 |
| Gottlieb A. Keller | 26 |
| Elias Zerhouni | 26 |
| John Greisch | 25 |
| Joseph Scodari | 24 |
| Severin Schwan | 23 |
| Hendrica Verhagen | 22 |
| Mathieu Simon | 22 |
- Börse
- Insiders
- Jean-Paul Clozel
- Unternehmensverbindungen
